FDA

The supplemental approval expands KetoMed's existing label to include a new species and indication, offering veterinarians a generic alternative to the brand-name Ketofen.

A newly conditionally approved treatment for a painful neurologic condition in dogs, the first detection of pseudorabies in US commercial swine in more than 20 years, and a nationwide raw pet food recall over Salmonella contamination.

Following a successful 6-month feeding study, the FDA has issued a letter of no objection for a precision fermentation-derived lamb protein developed for use in adult dog food.

Pregabalin chewable tablets target nerve-related pain by reducing the release of neurotransmitters involved in pain signaling within the spinal cord.

Further testing and evaluation are underway, according to Albright’s Raw Pet Food.

A first-of-its-kind FDA approval for canine behavioral conditions, a potential milestone in veterinary vaccine technology, and new research complicating the picture of how H5N1 moves through dairy farm environments.

This week: a first-of-its-kind feline hypertension approval, an experimental injectable for flat-faced dogs, and a sweeping new look at cancer genes in cats.

After years of off-label use, veterinarians now have the first FDA-approved amlodipine formulation specifically indicated for cats with systemic hypertension.

The authorization adds to a growing list of treatments cleared under emergency use as federal agencies ramp up efforts to prevent New World screwworm from reestablishing in the United States.

A professional overview of compounding's role in modern medicine and the regulations that govern it.

The voluntary recall affects more than 300 lots of Webcol Large Alcohol Prep Pads used in veterinary clinics for surgical preparation and wound care.

Officials with the FDA are aiming to help drug developers validate new approach methodologies.

An FDA risk review has cleared the way for canine freeze-dried plasma, a shelf-stable product that could expand transfusion options in emergencies.

Atinvicitinib tablets (Numelvi) will control pruritus associated with allergic dermatitis in canines.

The FDA has issued a warning that multiple lots of Raaw Energy frozen dog food have tested positive for Listeria, Salmonella, Escherichia coli O157, and Campylobacter jejuni.

The FDA has approved potassium bromide chewable tablets (KBroVet) for managing canine idiopathic epilepsy.

The approval broadens the drug's label, which already covers the management of mild to severe congestive heart failure in dogs with clinical myxomatous mitral valve disease or dilated cardiomyopathy.

Robenacoxib tablets from ZyVet Animal Health are bioequivalent to Onsior (Elanco Animal Health).

Zygolide by Dechra offers a generic, bioequivalent option for managing pituitary pars intermedia dysfunction in horses.

Credelio Quattro (Elanco) was previously approved by the FDA for treatment of infestation for 6 other parasites in dogs.

The approval of Emeprev will help veterinary professionals by providing an in-clinic antiemetic option.

The product is also indicated treatment and control of cattle fever tick.

The FDA’s new draft guidance outlines when monoclonal antibody developers can reduce or eliminate 6-month primate studies

The FDA determined that Credelio Cat may be effective in treating New World screwworm infestations in cats and kittens.

The announcement comes as raw pet food products have tested positive for bird flu amid fall migratory season.

This completion is a crucial requirement in the approval process for a drug.

Solovecin by Dechra is a generic antibiotic for the treatment of skin infections in dogs and cats.

Felixvet has announced the approval for a bioequivalent product to Simplicef (Zoetis).